Differentiating hyperlipidaemia associated with antiretroviral therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 • 1,549 citations
Drug Treatment of Lipid Disorders
1999 • 863 citations
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
1972 • 843 citations
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
1992 • 784 citations
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
1999 • 615 citations
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
1995 • 569 citations
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
1999 • 533 citations
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
2000 • 527 citations
Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy
2000 • 465 citations
Hypertriglyceridemia in the acquired immunodeficiency syndrome
1989 • 446 citations
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
2000 • 398 citations
Fat distribution and metabolic changes in patients with HIV infection
1999 • 380 citations
Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study
2000 • 366 citations
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
1992 • 341 citations
Myocardial infarction in the familial forms of hypertriglyceridemia
1976 • 308 citations
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
1983 • 305 citations
Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy
2001 • 284 citations
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
2000 • 249 citations
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection
2000 • 197 citations
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
2000 • 192 citations
Vascular complications associated with use of HIV protease inhibitors
1998 • 168 citations
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors☆☆☆★
2002 • 127 citations
Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex
1992 • 104 citations
Antiretroviral therapy-associated hyperlipidaemia in HIV disease
2001 • 101 citations
Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy
2001 • 80 citations
Severe hypertriglyceridemia: Role of familial and acquired disorders
1983 • 71 citations
Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity
2001 • 69 citations
Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy
2001 • 26 citations